REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/06/2025
Voltar para busca
Dado oficial do USPTO
LOX-INDEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
03/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
19/06/2019
Data de registro
02/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/06/2020
Última transação
03/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Supplemental Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Minato-ku, Tokyo, JP
Examinador
TOY,JOSHUA SPENCER JOLL
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NK Medico co., LTD.
NK Medico co., LTD.
Representantes
M. Scott Alprin ALPRIN LAW OFFICES, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic biomarker reagents for medical purposes; Medical diagnostic reagents and assays for testing of blood samples taken from patients; Diagnostic reagents for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing blood samples taken from patients; Diagnostic kits comprising diagnostic agentspreparations and substances for medical use; Diagnostic biomarker reagents for medicinal use in the field of arteriosclerosis risk; Diagnostic biomarker reagents for medicinal use in the field of risk of heart diseases; Diagnostic biomarker reagents for medicinal use in the field of risk of cerebral diseases; Diagnostic biomarker reagents for medicinal use in the field of risk of a cerebral and a myocardial infarction; Diagnostic reagents for medicinal use in the field of arteriosclerosis; Diagnostic reagents for medicinal use in the field of heart diseases; Diagnostic reagents for medicinal use in the field of cerebral diseases; Diagnostic reagents for medicinal use in the field of a cerebral infarction and a myocardial infarction
Classe 42
Scientific research services for medical purpose; Scientific research for medical purposes in the area of cerebral infarction; Scientific research for medical purposes in the area of myocardial infarction; Scientific research for medical purposes in the area of cerebrovascular diseases; Scientific research for medical purposes in the area of heart diseases; Scientific research for medical purposes in the area of arteriosclerosis; Design and development of medical technology in the field of surgical robots; Research and development in the field of diagnostic preparations; Testing of pharmaceuticals; Scientific and medical research and development in the field of pharmaceuticals; Consultancy relating to pharmaceutical research and development; Research on the subject of pharmaceuticals; Development of pharmaceutical preparations and medicines; Design and development of medical diagnostic apparatus; Medical research; Biotechnology research; Conducting technical project studies in the nature of scientific feasibility studies; Scientific laboratory services; Scientific research; Technological research in the field of medical instruments; Design and development of computer hardware and software for medical technology for use in the field of medicine
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/09/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/09/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/09/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/09/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/09/2020
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
02/06/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
28/04/2020
ALIE
ASSIGNED TO LIE
21/04/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
13/04/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
13/04/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/04/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
13/04/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/04/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
13/04/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
07/04/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
07/04/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/04/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
07/04/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/03/2020
ALIE
ASSIGNED TO LIE
20/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2019
GNRT
NON-FINAL ACTION E-MAILED
12/09/2019
CNRT
NON-FINAL ACTION WRITTEN
12/09/2019
DOCK
ASSIGNED TO EXAMINER
11/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/06/2019
NWAP
NEW APPLICATION ENTERED
22/06/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LOX-INDEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.